Atopic dermatitis (eczema) trials in United States
24 of 77 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleNatural History and Genetics of Food Allergy and Related Conditions
- Where
- Bethesda
- Age
- 1 day to 99 years
- People
- 1,800
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02504853 - No phaseTaking peopleEvaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Where
- Caledonia, Columbus, Henderson, Las Vegas, Lee's Summit, Longview, Los Angeles, Missouri City, Morgantown, New York, Norfolk, Phoenix, Portsmouth, Rockville, South Jordan, Tampa
- Age
- 12 years to 89 years
- People
- 450
- Run by
- Castle Biosciences Incorporated
See details and how to joinNCT07645820 - No phaseTaking peopleBlood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 200
- Run by
- University of Pittsburgh
See details and how to joinNCT00177268 - No phaseTaking peopleStudies of Skin Microbes in Healthy People and in People With Skin Conditions
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 530
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT00605878 - No phaseTaking peopleMetabolic Profiling of Immune Responses in Immune-mediated Diseases
- Where
- Bethesda
- Age
- 18 years to 75 years
- People
- 300
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04864886 - No phaseTaking peopleThis Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Where
- Albuquerque, Ann Arbor, Auburn Hills, Bakersfield, Bay City, Birmingham, Bolivar, Bountiful, Caledonia, Dallas, Detroit, Doral, Falls Church, Fargo, Fort Worth, Fremont, Gilbert, Huntersville, Kirksville, Las Vegas, Lincoln, Los Angeles, Macon, Marion, Mason, Mill Creek, Montgomery, Normal, North Chicago, North Miami Beach, Northridge, Oakland, Pflugerville, Phoenix, Pittsburgh, Pomona, Portsmouth, San Diego, Seattle, Spartanburg, Springville, Sugar Land, Warwick, Waterford, Wheat Ridge, Winston-Salem
- Age
- 12 years and over
- People
- 1,000 worldwide
- Run by
- Sanofi
See details and how to joinNCT07290803 - No phaseTaking peopleA Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- Where
- Bethesda
- Age
- 3 years to 100 years
- People
- 10,000
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06732414 - No phaseNot yet taking people in United StatesAn Observational Study of Patients With Dermatologic Disease
- Where
- New York
- People
- 2,000,000
- Run by
- Target PharmaSolutions, Inc.
See details and how to joinNCT07748169 - No phaseTaking peopleCorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
- Where
- Waltham
- Age
- 18 years and over
- People
- 10,000
- Run by
- CorEvitas
See details and how to joinNCT04504955 - No phaseTaking peoplePPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Age
- 18 years and over
- People
- 2,000
- Run by
- CorEvitas
See details and how to joinNCT07598058 - No phaseTaking peopleReal World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Where
- San Diego
- Age
- 12 years and over
- People
- 150
- Run by
- Pfizer
See details and how to joinNCT06899204 - No phaseTaking peopleSkin Microbial Ecology in Atopic Dermatitis
- Where
- Rochester
- Age
- 13 years and over
- People
- 240
- Run by
- University of Rochester
See details and how to joinNCT04170244 - No phaseTaking peopleSodium in the Skin and Atopic Dermatitis
- Where
- San Francisco
- Age
- 50 years and over
- People
- 90
- Run by
- University of California, San Francisco
See details and how to joinNCT06998446 - No phaseTaking peopleCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Age
- 10 years to 15 years
- People
- 1,500
- Run by
- CorEvitas
See details and how to joinNCT06238765 - No phaseTaking peopleMechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
- Where
- Boston
- Age
- 6 years to 65 years
- People
- 111
- Run by
- Boston Children's Hospital
See details and how to joinNCT04455906 - No phaseEnrolling by invitationInvestigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
- Where
- Philadelphia
- People
- 300
- Run by
- University of Pennsylvania
See details and how to joinNCT06464133 - No phaseTaking peopleRegistry for Systemic Eczema Treatments
- Where
- Baltimore
- Age
- 1 year to 26 years
- People
- 400
- Run by
- Johns Hopkins University
See details and how to joinNCT06136767 - No phaseTaking peopleReal-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Where
- Auburn, Auburn Hills, Birmingham, Bluffton, Boca Raton, Bountiful, Brighton, Caledonia, Castle Rock, Cedar Park, Chicago, Columbia, Coral Gables, Corona, Cutler Bay, Dallas, Dayton, East Syracuse, Edinburg, Fairfield, Fountain Valley, Fremont, Glenn Dale, Grandville, Grapevine, Gresham, Hollywood, Indianapolis, Jupiter, Las Vegas, Lee's Summit, Los Angeles, Miami, Milford, Morgantown, Mount Kisco, Newport Beach, New York, North Miami Beach, Oakland Park, Philadelphia, Phoenix, Portsmouth, Rockville, Santa Monica, St. Petersburg, Sugar Land, Tampa, Thousand Oaks, Troy, Tucson, Vienna, Waco, West Lafayette
- Age
- 12 years and over
- People
- 1,000 worldwide
- Run by
- Galderma R&D
See details and how to joinNCT06988605 - No phaseTaking peopleAllergy and Immunology Natural History Study
- Where
- New York
- Age
- Up to 99 years
- People
- 10,000
- Run by
- Columbia University
See details and how to joinNCT05584488 - No phaseTaking peopleStudy to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- Where
- Morrisville
- Age
- 15 years to 50 years
- People
- 958
- Run by
- Incyte Corporation
See details and how to joinNCT06259669 - No phaseTaking peopleAn Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- Where
- Morrisville
- Age
- 14 years and over
- People
- 5,621
- Run by
- Incyte Corporation
See details and how to joinNCT06627335 - No phaseTaking peopleA Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Where
- New York
- Age
- 0 years and over
- People
- 400
- Run by
- Pfizer
See details and how to joinNCT05721937 - No phaseTaking peopleMonitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
- Where
- La Jolla
- People
- 900
- Run by
- University of California, San Diego
See details and how to joinNCT05938478 - No phaseNot yet taking people in United StatesInvestigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
- Where
- San Francisco
- Age
- 18 years and over
- People
- 500
- Run by
- Power Life Sciences Inc.
See details and how to joinNCT06174493